Abstract:BACKGROUND:Both pharmacologic and genetic approaches have been used to study the involvement of the muscarinic acetylcholine system in the regulation of chronic pain. Previous studies suggest that the M2 and M4 subtypes of muscarinic acetylcholine receptors (mAChRs) are important targets for the development of chronic pain. (5R,6R)6-(3-Propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1] octane (PTAC) has agonist effects on muscarinic M2 and M4 receptors and antagonist effects on muscarinic M1, M3, and M5 receptors. However, its analgesic effects have been less studied. METHODS:Male C57B L/6 mice were anesthetized, and left common peroneal nerve (CPN) ligation was performed to induce neuropathic pain. Before and after the application of PTAC systemically or specifically to the anterior cingulate cortex (ACC), the withdrawal thresholds to mechanical stimulation and static weight balance were measured, and the effects of PTAC on the conditioned place preference (CPP) were further evaluated. Western blotting was used to examine the expression of M1 and M2 in the striatum, ACC, and ventral tegmental area. RESULTS:The application of PTAC ([i.p.] intraperitoneal injection) increased the paw withdraw threshold in both the early (0.05 mg/kg, mean difference [95% confidence interval, CI]: 0.19 [0.05-0.32]; 0.10 mg/kg: mean difference [95% CI]: 0.34 [0.22-0.46]) and the late phases (0.05 mg/kg: mean difference [95% CI]: 0.45 [0.39-0.50]; 0.1 mg/kg: mean difference [95% CI]: 0.44 [0.37-0.51]) after nerve injury and rebalanced the weight distribution on the hind paws of mice (L/R ratio: before, 0.56 ± 0.03. 0.05 mg/kg, 1.00 ± 0.04, 0.10 mg/kg, 0.99 ± 0.03); however, it failed to induce place preference in the CPP (0.05 mg/kg, 2-way analysis of variance, P > .05; 0.2 mg/kg, 2-way analysis of variance, P > .05,). At the same doses, the analgesic effects at D3-5 lasted longer than the effects at D14-16. This may be due to the down-regulation of the M2 and M1 in tested brain regions. CONCLUSIONS:These observations suggested that PTAC has analgesic effects on the neuropathic pain induced by nerve injury.

1,8-cineole decreases neuropathic pain probably via a mechanism mediating P2X3 receptor in the dorsal root ganglion

Effects of 1,8-Cineole on Neuropathic Pain Mediated by P2X2 Receptor in the Spinal Cord Dorsal Horn

Effect of 1,8-cineole on neuropathic pain mediated by P2X3 receptor in the dorsal root ganglions

Blocking Cx43 Alleviates Neuropathic Pain in Rats with Chronic Constriction Injury Via the P2X4 and P38/ERK-P65 Pathways

Cyclooxygenase inhibitors suppress the expression of P2X3 receptors in the DRG and attenuate hyperalgesia following chronic constriction injury in rats

The Analgesic Effects of (5R,6R)6-(3-Propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1] Octane on a Mouse Model of Neuropathic Pain.

Blocking Cx43 alleviates neuropathic pain mediated by P2X4 receptor in CCI rats

Effects of 1,8-cineole on Na(+) currents of dissociated superior cervical ganglia neurons

Ameliorating Effects of 1,8-Cineole on LPS-induced Human Umbilical Vein Endothelial Cell Injury by Suppressing NF-κB Signaling in Vitro.

P2X3 and P2X2/3 receptors inhibition produces a consistent analgesic efficacy: A systematic review and meta-analysis of preclinical studies

Neuroprotective Effect of Anethole Against Neuropathic Pain Induced by Chronic Constriction Injury of the Sciatic Nerve in Mice

Role of cyclooxygenases in up-regulation of P2X3 receptor expression in dorsal root ganglion in rats with neuropathic pain

Effect of emodin on neuropathic pain transmission mediated by P2X2/3 receptor of primary sensory neurons.

Carbenoxolone has the potential to ameliorate acute incision pain in rats

The analgesic effect and mechanism of the active components screening from Corydalis yanhusuo by P2X3 receptors

1,8-Cineole Ameliorates LPS-Induced Vascular Endothelium Dysfunction in Mice Via PPAR-γ Dependent Regulation of NF-κB

Antinociceptive Effect of Isoorientin Against Neuropathic Pain Induced by the Chronic Constriction Injury of the Sciatic Nerve in Mice.

Antinociceptive Effect of Spirocyclopiperazinium Salt Compound DXL-A-24 and the Underlying Mechanism

Therapeutic Effects of Combined Treatment with the AEA Hydrolysis Inhibitor PF04457845 and the Substrate Selective COX-2 Inhibitor LM4131 in the Mouse Model of Neuropathic Pain

1,8-cineole ameliorates colon injury by downregulating macrophage M1 polarization via inhibiting the HSP90-NLRP3-SGT1 complex

Microencapsulated Olfactory Ensheathing-Cell Transplantation Reduces Pain in Rats by Inhibiting P2X4 Receptor Overexpression in the Dorsal Root Ganglion